Who invested in Mirum Pharmaceuticals?
Mirum Pharmaceuticals's investors include New Enterprise Associates, Novo Holdings, TCG and TCG Crossover.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$669Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $68M sold, first sale Jan 2026
Source recordedSEC filing: $68M sold, first sale Jan 2026
From Mirum Pharmaceuticals's own website: 10 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Mirum Pharmaceuticals's investors include New Enterprise Associates, Novo Holdings, TCG and TCG Crossover.
Mirum Pharmaceuticals has raised $669M across 2 rounds since 2025.
Mirum Pharmaceuticals's most recent round was a Debt of $600M in May 2026.
Its most recent round, $600M in May 2026, is also its largest on record.
Mirum Pharmaceuticals's first round on record, in Dec 2025, was backed by New Enterprise Associates, Novo Holdings and TCG and 1 others.
Mirum Pharmaceuticals's latest named round is a Debt, in May 2026.
Mirum Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.